although
equin
viral
arter
known
almost
year
diseas
outbreak
identifi
infrequ
field
isol
caus
agent
equin
arter
viru
eav
rare
report
host
eav
hors
clinic
sign
infect
vari
wide
sever
form
eav
infect
caus
abort
earli
veterinari
literatur
viral
arter
refer
epizoot
cellul
pinkey
equin
influenza
potti
clark
eav
type
strain
bucyru
owe
name
town
ohio
first
isol
abort
storm
doll
et
al
equin
viral
arter
transmit
respiratori
rout
mccollum
et
al
howev
carrier
state
exist
seroposit
stallion
eav
produc
semen
timoney
shed
stallion
may
consequ
infect
broodmar
vener
rout
chang
regul
part
european
commun
singl
market
economi
could
advers
affect
diseas
free
statu
uk
regard
viral
arter
seroposit
anim
continent
europ
could
introduc
diseas
britain
excel
review
subject
publish
describ
epidemiolog
patholog
eav
mumford
huntingdon
et
al
articl
aim
updat
reader
result
recent
research
br
vet
j
investig
molecular
structur
equin
arter
viru
inform
strategi
clinic
diagnosi
viru
detect
diseas
control
prevent
outbreak
eav
occur
usa
doll
et
al
mccollum
swerczek
timoney
mccollum
timoney
et
al
collin
et
al
hall
switzerland
burki
gerber
et
al
poland
golnik
et
al
golnik
austria
nowotni
canada
clayton
carman
addit
serosurvey
identifi
antibodi
posit
hors
england
japan
mccollum
bryan
franc
spain
ireland
portug
yugoslavia
egypt
ethiopia
morocco
seneg
moraillon
moraillon
ussr
akashi
et
al
germani
kaaden
et
al
sweden
klingeborn
et
al
australia
huntingdon
et
al
new
zealand
mckenzi
mckenzi
iran
maasommeh
india
denmark
chirnsid
unpublish
netherland
de
boer
et
al
semen
shedder
eav
report
present
usa
timoney
australia
huntingdon
et
al
sweden
klingeborn
et
al
itali
autorino
et
al
mani
serolog
report
hors
categor
breed
type
howev
usa
australia
mani
standardbr
seroposit
eav
contrast
thoroughbr
seroposit
timoney
mccollum
huntingdon
et
al
indic
differ
diseas
exposur
suscept
within
breed
mani
case
importexport
serolog
data
compil
serosurvey
report
tend
distort
number
countri
harbour
seroposit
anim
hors
question
may
origin
elsewher
date
unit
kingdom
remain
free
outbreak
eav
due
geograph
isol
mainland
europ
strict
import
restrict
introduc
requir
test
hors
antibodi
eav
viru
neutral
test
howev
singl
market
economi
legisl
european
commun
take
effect
elimin
import
requir
eav
neutral
test
hors
enter
uk
ec
member
state
consequ
eavsuscept
uk
equin
popul
increas
risk
diseas
number
serum
sampl
test
eav
antibodi
anim
health
trust
sinc
shown
tabl
data
show
preval
uk
thoroughbr
serum
neutral
antibodi
eav
low
major
sera
come
hors
move
onto
stud
farm
newmarket
area
eav
seroposit
anim
detect
histori
commensur
infect
whilst
stud
duti
abroad
australia
new
zealand
serosurvey
indic
seroposit
anim
import
huntingdon
et
al
mckenzi
associ
risk
shed
stallion
dissemin
viru
vener
situat
regard
uk
nativ
hors
breed
thoroughbr
unknown
like
reflect
european
countri
low
preval
seroposit
anim
due
subclin
eav
infect
consequ
eav
infect
rang
subclin
diseas
recogn
seroconvers
mccollum
bryan
acut
ill
caus
full
blown
abortigen
diseas
studi
epizoot
shown
subclin
infect
sixfold
preval
clinic
infect
timonev
mccollum
collin
et
al
acut
diseas
clinic
sign
arc
variabl
includ
pyrexia
depress
anorexia
oedema
scrotum
ventral
trunk
limb
conjunct
lacrim
serou
nasal
discharg
respiratori
distress
clinic
sign
associ
arter
includ
lame
cough
gener
weak
ataxia
doll
et
al
gerber
pt
al
clayton
collin
et
al
timonev
et
al
adult
hors
gener
make
unev
recoveri
viraem
phase
may
persist
day
infect
neu
et
al
howev
eav
infect
may
caus
foal
death
carman
timonev
mccollum
dolnik
major
fear
clinic
diseas
abort
incid
expos
mare
eav
may
caus
abort
mare
month
gestat
timoney
mccollum
cole
et
al
abort
may
occur
concurr
shortli
infect
doll
et
al
golnik
et
al
timoney
et
al
clayton
result
mvometri
necrosi
oedema
lead
placent
detach
fetal
death
coignoul
clhevil
recent
chief
mode
viru
transmiss
eav
outbreak
report
direct
contact
via
nasal
droplet
spray
mccollum
et
al
acut
phase
infect
kentucki
outbreak
high
percentag
stallion
infect
respiratori
rout
continu
shed
viru
semen
recoveri
timonev
result
transmiss
eav
suscept
mare
bred
two
carrier
state
exist
stallion
shortterm
state
convalesc
durationweek
longterm
chronic
condit
timoney
timonev
et
al
report
mare
becom
eav
carrier
chronic
shedder
viru
passag
vener
rout
seroposit
mare
caus
clinic
diseas
seroconvers
stallion
foal
born
seroposit
mare
acquir
matern
antibodi
eav
via
colostrum
mccollum
matern
antibodi
declin
extinct
month
result
foal
becom
seroneg
unless
infect
eav
clinic
recoveri
respiratori
eav
infect
signific
decreas
fertil
shed
stallion
timoney
et
al
klingeborn
et
al
mare
infect
servic
carrier
stallion
appear
relat
fertil
problem
sampl
select
order
confirm
diagnosi
viral
arter
correct
sampl
must
submit
laboratori
test
case
respiratori
diseas
whole
clot
blood
nasopharyng
swab
store
viru
transport
medium
taken
submit
quickli
possibl
diagnost
laboratori
clinic
histori
recent
transport
histori
hors
may
also
help
select
laboratori
test
corticosteroid
cytotox
cell
type
tissu
cultur
interfer
eav
neutral
test
drug
alreadi
prescrib
note
eav
abort
fetu
placenta
heavili
contamin
viru
cole
et
al
sampl
collect
steril
manner
submit
viru
isol
eav
isol
placenta
fetal
spleen
lung
kidney
fetal
placent
fluid
semen
sampl
collect
stallion
suspect
shed
viru
sampl
sperm
rich
fraction
full
ejaculatesnot
dismount
samplesand
store
rapid
transport
laboratori
addit
serum
sampl
mare
stallion
bred
within
last
month
provid
addit
inform
infect
statu
stallion
viru
isol
acut
viral
arter
may
diagnos
viru
isol
front
nasopharyng
swab
wash
buffi
coat
edtatr
citrat
blood
sampl
geer
forman
diagnosi
abort
due
eav
larg
depend
viru
isol
placenta
fetal
tissu
eav
isol
directli
equin
kidney
rabbit
kidney
rk
vero
cell
burki
golnik
et
al
serial
blind
passag
materi
abort
fetus
foal
latter
case
cytopath
effect
cpe
recogniz
passag
isol
eav
field
case
prove
difficult
incid
fail
nasopharyng
swab
taken
febril
hors
outbreak
switzerland
gerber
et
al
swab
huffi
coat
outbreak
kentucki
mccollum
swerczek
produc
cpe
tissu
cultur
inocul
latter
worker
abl
show
viru
transmiss
inocul
blood
febril
hors
suscept
anim
follow
viru
isol
nasal
swab
blood
experiment
infect
hors
eav
carrier
state
first
demonstr
natur
infect
stallion
test
mate
viru
isol
rk
cell
timoney
et
al
timoney
et
al
viru
cultur
semen
sampl
current
recogn
method
identifi
shed
stallion
recent
new
method
independ
viru
isol
tissu
cultur
use
demonstr
presenc
eav
semen
sampl
chirnsid
spaan
methodolog
detect
plaqu
form
unitsml
semen
sensit
tissu
cultur
isol
purifi
viral
rna
first
transcrib
copi
dna
cdna
prior
amplif
polymeras
chain
reaction
pcr
cdna
amplif
eavspecif
oligonucleotid
primer
enzym
taq
polymeras
amplifi
quantiti
eav
cdna
product
pcr
amplif
separ
agaros
gel
electrophoresi
eavspecif
cdna
band
visual
uv
light
gel
probe
radiolabel
oligonucleotid
confirm
cdna
product
eavspecif
advantag
methodolog
tissu
cultur
iii
speed
viru
detect
h
compar
week
speciticiln
eav
rna
detect
applic
wide
rang
clinic
sampl
depend
entir
viru
present
viral
rna
klingehorn
et
al
use
methodolog
confirm
tissu
cultur
isol
result
swedish
semen
shedder
serolog
antibodi
eav
demonstr
complement
fixat
cf
viru
neutral
vn
test
burki
matsumoto
et
al
burki
gerber
hyllseth
petersson
cf
test
use
studi
immun
arter
first
month
exposur
titr
peak
week
infect
decreas
detect
limit
month
fukanaga
mccollum
cf
antibodi
role
diagnos
recent
infect
decreas
rapidli
vn
antibodi
titr
v
n
antibodi
titr
develop
simultan
cf
titr
maxim
month
infect
remain
stabl
sever
year
gerber
et
al
laboratori
diagnosi
seroposit
hors
base
complement
depend
vn
test
use
bucyru
strain
eav
tissu
cultur
infect
senn
et
al
two
laboratori
uk
earn
standard
test
central
veterinari
laboratori
weybridg
exportimport
document
anim
health
trust
newmarket
titr
duplic
sera
deem
eav
seroposit
vn
test
procedur
although
expens
labori
cf
test
sensit
detect
immun
eav
result
previou
exposur
viru
vn
test
unabl
differenti
serum
antibodi
elicit
vaccin
due
natur
infect
enzym
link
immunosorb
assay
elisa
test
develop
canada
ling
mitchel
england
look
et
al
detect
eavspecit
antibodi
level
use
purifi
ea
antigen
elisa
recogn
eavposit
hors
sera
major
problem
encount
eav
elisa
failur
provid
clear
sensit
result
hors
test
previous
vaccin
anv
tissu
cultlir
deriv
virrn
trein
british
veterinari
journal
use
prevent
equin
influenza
herpesviru
infect
case
high
background
colour
develop
due
nonspecif
bind
antibodi
tissu
cultur
deriv
antigen
mask
eav
elisa
result
eav
small
envelop
positivestrand
rna
viru
virion
diamet
nm
hyllseth
consist
isometr
core
nm
surround
envelop
carri
ringlik
subunit
diamet
nm
murphi
horzinek
basi
virion
morpholog
substructur
size
eav
classifi
nonarthropod
born
member
togavirida
porterfield
et
al
westaway
et
al
eav
resist
trypsin
ether
sensit
inactiv
magnesium
chlorid
burki
buoyant
densiti
infecti
viru
calcul
gml
hyllseth
singlestrand
infecti
rna
molecular
weight
van
der
zeijst
et
al
kb
long
den
boon
et
al
current
one
recogn
serotyp
eav
although
evid
antigen
variat
amongst
differ
isol
fukunaga
mccollum
murphi
et
al
fig
overlap
region
nucleotid
presenc
shifti
heptanucleotid
sequenc
region
downstream
rna
pseudoknot
structur
indic
orf
lb
probabl
express
frameshift
frameshift
potenti
orf
lalb
overlap
region
demonstr
use
report
gene
orf
express
six
subgenom
mrna
fig
transcrib
portion
viral
genom
number
orf
predict
encod
structur
eav
protein
tabl
ii
orfla
equin
arter
viru
protein
locat
virion
surfac
receptor
protein
locat
surfac
host
cell
invas
host
cell
viral
genom
direct
synthesi
new
viru
particl
overrid
normal
cell
function
direct
cellular
machineri
synthes
viral
protein
one
initi
requir
synthesi
new
eav
protein
amplif
viral
genom
produc
multipl
mrna
encod
virusspecif
protein
methodolog
eav
genom
signal
amplifi
uniqu
facilit
organ
eav
gene
viral
genom
leaderpolvmeras
genesenvelop
genesnucleocapsid
gene
eav
replic
six
subgenom
rna
sgrna
synthes
van
berlo
et
al
form
nest
set
sgrna
conimon
end
extend
toward
end
genom
rna
differ
length
fig
leader
sequenc
nucleotid
found
end
sgrna
de
vri
et
al
leader
sequenc
deriv
end
genom
rna
join
bodi
mrna
posit
defin
nucleotid
sequenc
result
leaderbodi
join
orf
locat
uniqu
termin
region
sgrna
complet
eav
genom
contain
ucaac
motif
genom
orf
except
lb
preceed
one
motif
orf
leaderbodi
assembl
fulli
investig
thought
precis
util
one
avail
ucaac
site
upstream
orf
detect
heterogen
length
leader
sequenc
deduc
primer
extens
analysi
sever
subgenom
cdna
clone
de
vri
et
al
invitro
translat
eav
genom
rna
result
product
protein
kda
kda
rna
intracellular
homologu
genom
rna
synthes
kda
protein
van
berlo
et
al
rna
kda
protein
identifi
nucleocapsid
den
boon
et
de
vri
unpublish
synthesi
multipl
sgrna
uniqu
encod
differ
viral
orf
end
resembl
coronaand
torovir
sgrna
structur
organ
spaan
et
al
except
orf
coronavir
sgrna
translat
protein
spaan
et
al
function
coronaand
torovir
sgrna
appear
posit
intern
gene
uniqu
end
mrna
translat
protein
although
unproven
presum
case
arterivir
sgrna
protein
composit
eav
analys
radiolabel
viru
protein
tissu
cultur
infect
hyllseth
comparison
protein
pattern
viru
grown
differ
cell
type
zeeger
et
al
initi
studi
indic
protein
viru
associ
includ
kda
phosphoryl
nucleocapsid
kda
glycosyl
protein
kda
membraneassoci
protein
zeeger
et
al
addit
protein
smear
kda
size
rang
monoclon
antibodi
identifi
three
viru
specif
protein
mol
wt
kda
kda
kda
chirnsid
et
unpublish
western
blot
immunoprecipit
whole
viru
analysi
genom
sequenc
eav
den
boon
et
al
tabl
ii
confirm
protein
size
detect
earlier
method
eav
orf
encod
polypeptid
hydrophob
n
c
termini
orf
protein
british
veterinari
small
envelop
hydrophob
n
terminu
intern
hydrophob
domain
predict
protein
orf
contain
nglycosyl
site
could
therefor
encod
envelop
protein
kda
size
rang
orf
encod
unglycosyl
triplespan
membran
protein
product
orf
identifi
nucleocapsid
protein
van
berlo
et
al
de
vri
et
al
unpublish
figur
schemat
diagram
eav
base
size
properti
predict
locat
viru
encod
protein
puls
chase
experi
indic
viral
structur
protein
aris
process
larger
precursor
van
berlo
et
al
primari
translat
product
data
avail
rna
sequenc
level
ascertain
differ
exist
isol
eav
comparison
publish
sequenc
bucyru
prototyp
howev
eav
isol
usa
europ
show
differ
oligonucleotid
fingerprint
pattern
murphi
et
al
recent
north
american
isol
appear
homolog
bucyru
strain
european
isol
indic
sequenc
differ
like
exist
isol
eav
isol
crossreact
equin
antiserum
rais
bucyru
strain
major
antigen
variat
shown
differ
isol
use
cf
test
fukunaga
mccollum
fourth
report
intern
committe
taxonomi
virus
list
eav
sole
member
genu
arteriviru
famili
togavirida
eav
fulfil
three
prerequisit
consid
togaviru
posit
ssrna
genom
lipid
envelop
icosahedr
nucleocapsid
recent
inform
regard
genom
organ
replic
strategi
eav
publish
de
vri
et
al
den
boon
et
al
current
classif
appear
unjustifi
eav
appear
ancestr
relat
coronaand
torovirus
basi
genom
organ
replic
strategi
propos
member
coronaviruslik
famili
virus
den
boon
et
al
howev
genom
size
virion
architectur
coronavirus
spaan
et
al
torovirus
horzinek
et
al
fundament
differ
arterivirus
attempt
made
find
antigen
relationship
togaviru
lactat
dehydrogenas
viru
ldv
affect
mice
eav
van
berl
et
al
howev
comparison
littl
success
partial
sequenc
ldv
genom
indic
ldv
nucleocapsid
protein
locat
extrem
end
genom
godeni
et
al
genom
organ
ldv
may
therefor
resembl
arteri
toroand
coronavirus
rather
alphavirus
virtual
natur
infect
hors
recov
eav
infect
although
fatal
induc
experiment
infect
pyrexia
stallion
lead
sperm
damag
temporari
infertil
treatment
nonsteroid
antiinflammatori
prepar
may
indic
control
pyrexia
littl
et
al
recent
demonstr
administ
testosteron
castrat
stallion
persist
eav
chronic
infect
stallion
mediat
either
directli
indirectli
testosteron
consequ
depend
presenc
test
addit
sever
unpublish
find
suggest
viral
persist
accessori
sex
gland
stallion
testosteron
depend
includ
failur
viru
persist
develop
prepubert
colt
season
fluctuat
viral
output
coincid
season
fluctuat
serum
testosteron
level
appar
elimin
eav
reproduct
tract
follow
castrat
absenc
carrier
state
mare
sexual
rest
follow
acut
eav
infect
may
import
reduc
likelihood
stallion
becom
chronic
eav
carrier
previous
infect
hors
immun
experiment
reinfect
virul
viru
mccollum
natur
immun
persist
year
gerber
et
al
although
difficult
demonstr
empir
presum
lifelong
recoveri
eav
infect
high
level
serum
neutral
antibodi
induc
long
durat
high
level
antibodi
correl
vetwel
protect
respiratori
vener
infect
research
work
eav
vaccin
concentr
safeti
efficaci
whole
inactiv
viru
vaccin
attenu
live
viru
vaccin
earli
studi
doll
et
al
demonstr
virul
eav
could
attenu
passag
tissu
cultur
whilst
retain
immunogen
serial
passag
hors
kidney
rabbit
kidney
equin
dermi
cell
serv
attenu
virul
viru
mccollum
mccollum
mccollum
harri
mccollum
mccollum
et
al
result
modifi
live
vaccin
mv
vaccin
receiv
widespread
use
kentucki
eav
outbreak
regist
use
state
within
usa
arvac
fort
dodg
laboratori
use
mix
produc
side
effect
apart
shortterm
abnorm
sperm
morpholog
mild
fever
overt
clinic
sign
viru
isol
sporad
nasopharynx
blood
sampl
gener
day
case
day
postvaccin
fukunaga
el
al
timonev
et
al
vaccin
viru
never
isol
semen
urin
vaccin
mi
v
fukunagaa
et
al
timoney
et
il
vn
antibodi
titr
induc
within
day
vaccin
timonev
et
al
persist
least
vear
mccollum
vaccin
mix
protect
clinic
diseas
reduc
atnount
viru
shed
respiratori
tract
experiment
infect
hors
contact
mare
serv
vaccin
stallion
infect
eav
mckinnon
et
al
timoney
et
al
vaccin
mare
experiment
challeng
artifici
insemin
protect
clinic
infect
howev
latter
worker
demonstr
need
vaccin
anim
isol
one
mare
close
contact
vaccin
vener
challeng
group
becam
eav
seroposit
modifi
live
eav
vaccin
use
good
effect
contain
arter
outbreak
kentucki
surd
farm
howev
vaccin
hors
induc
shed
viru
front
nasopharynx
prevent
infect
univers
accept
use
stud
farm
within
train
stabl
problem
address
cowork
pioneer
use
formalin
inactiv
eav
vaccin
secondari
immun
week
primari
vaccin
result
vn
antibodi
titr
antibodi
titr
decreas
rapidli
third
immun
month
result
vn
titr
persist
month
protect
level
antibodi
calcul
vn
titr
howev
even
though
clinic
diseas
avert
veterinari
rnal
hors
high
antibodi
level
protect
infect
live
viru
recov
blood
sampl
experiment
exposur
valu
type
vaccin
diseas
control
within
stabl
unclear
unknown
vaccin
hors
show
reduc
level
viru
excret
rnasopharynx
recent
inactiv
vaccin
heen
shown
prevent
stallion
becom
semen
shedder
exposur
eav
fukunaga
et
al
efficaci
eav
diseas
programm
conduct
kentucki
sinc
diseas
outbreak
outbreak
spread
eav
control
movement
restrict
isol
infect
anim
stud
farm
follow
quarantin
period
recoveri
alloc
personnel
deal
sole
infect
anim
diagnost
surveil
use
modifi
live
vaccin
immun
anim
risk
infect
diseas
outbreak
subsequ
vaccin
result
popul
seroposit
anim
due
infect
live
viru
immun
group
potenti
infect
suscept
anim
brought
close
contact
result
strict
eav
control
programm
conduct
sinc
involv
annual
vaccin
noncarri
stallion
teaser
prior
breed
season
vaccin
seroneg
mare
serv
carrier
stallion
follow
vaccin
anim
isol
day
nonvaccin
hors
addit
mare
bred
seroposit
stallion
isol
day
servic
shed
stallion
hous
bred
separ
facil
seroposit
nonshed
stallion
check
two
season
monitor
serolog
statu
mare
bred
stallion
stallion
mare
becom
clinic
infect
breed
season
use
season
use
vaccin
integr
part
eav
control
programm
also
advoc
state
new
york
new
zealand
mckenzi
remain
option
area
either
clinic
diseas
seroposit
anim
exist
howev
widespread
vaccin
hors
modifi
live
eav
vaccin
entail
risk
vaccin
viru
could
revert
virul
vaccin
could
spread
attenu
strain
outwith
vaccin
programm
either
viru
shed
directli
vaccin
induc
semen
shedder
appear
occur
kentucki
howev
equin
popul
free
diseas
seroposit
anim
import
regul
exclud
seroposit
clinic
ill
anim
togeth
intern
diagnost
surveil
safest
effect
method
diseas
prevent
event
new
outbreak
occur
within
suscept
popul
manag
procedur
follow
practis
kentucki
substitut
kill
subunit
vaccin
modifi
live
vaccin
understand
viru
caus
equin
arter
recent
improv
due
determin
genom
nucleotid
sequenc
equin
arter
viru
eav
den
boon
et
al
addit
knowledg
diseas
process
effect
necessarili
improv
wake
outbreak
viral
arter
amongst
thoroughbr
hors
kentucki
stud
farm
timoney
serosurvey
viru
isol
data
show
equin
viral
arter
exist
within
ec
sinc
diseas
passag
seroposit
stallion
mare
unreason
expect
chang
import
requir
uk
remain
free
diseas
consequ
uk
veterinarian
need
inform
aspect
eav
diseas
diagnosi
manag
eavspecif
protein
identifi
genom
sequenc
studi
investig
function
viru
structur
replic
assembl
determin
antigen
stimul
protect
immun
hors
studi
provid
vital
inform
develop
novel
eav
vaccin
diagnost
test
addit
eav
appear
stimul
protect
immun
long
durat
hors
immunoprophylaxi
suitabl
equin
viru
infect
inay
develop
directli
research
eav
data
mechan
eav
respiratori
viru
develop
chronic
vener
infect
vice
versa
littl
known
strain
variat
amongst
isol
eav
eav
isol
respiratori
tract
differ
genom
antigen
viru
present
accessori
sex
gland
eav
avoid
immunosurveil
carrier
stallion
seroposit
stallion
shed
viru
antigen
compon
viru
respons
stimul
immun
interact
equin
immun
system
provid
host
protect
mani
question
still
answer
eav
remain
subject
continu
scientif
scrutini
lion
diseas
lexinglon
ed
powel
pp
lexington
univers
press
ul
spaan
w
j
bredenbeek
p
chirnsid
e
et
al
compar
